The trial that changed my life: Tae Moise shares his journey in gene editing for sickle cell disease

Event details

What does cutting-edge gene editing research mean for the people it aims to help? Join us for a powerful personal perspective from Tae Moise, who participated in a groundbreaking clinical trial for sickle cell disease at The Ottawa Hospital. Tae will share his journey from frequent hospitalizations and debilitating pain to a dramatically different life following treatment. His story offers a unique window into the human impact of clinical trials and the promise of gene editing therapies for people living with serious genetic diseases. 

Tae will be introduced by Dr. Harold Atkins, the hematologist and clinician investigator who enrolled him in the study and co-authored the results, published in the New England Journal of Medicine. 

Opening remarks will be given by Cameron Love, President and CEO of The Ottawa Hospital and Dr. Rebecca Auer, Executive Vice-President of Research and Innovation.

This event is part of Research Week at The Ottawa Hospital (and Clinical Research Staff Training Day) and is open to all members of the hospital and research institute. If you wish to join virtually but did not receive the link, email the contact below. 

Event contact